What do you want to see in OTE in 2009?

Article

Fill in OTE's online readership survey for the chance to win €500 Marriott hotel vouchers.

This month we are launching our readership survey, which gives you the chance to get involved.

For me, this survey is incredibly important; it gives me the chance to read your thoughts alongside those of your fellow subscribers. I place such a huge emphasis on the results of this survey. It tells me what we are doing right, what we can improve on, what you want to see more of and, ultimately, how we can serve you better. So I urge you take the time to complete this online form, which is available on our website ( http://www.oteurope.com/readers/).

If the opportunity of having direct input into OTE's editorial direction from 2009 onwards isn't enough of an incentive for you, then let me also tell you that all survey respondents will be entered into a prize draw to win €500 of Marriott Hotel vouchers. These can be used either for business or pleasure and will be redeemable in all Marriott Hotels, globally. The winner will be announced on our website ( http://www.oteurope.com/) in August as well as in the print edition of OTE in September.

Best of luck and thank you!

Fedra PavlouEditor

Recent Videos
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
© 2024 MJH Life Sciences

All rights reserved.